Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Shangqian Wang, M.D.,PhD
CONTACT
Lead
The First Affiliated Hospital with Nanjing Medical University
Primary Study Endpoints: Radiographic progression-free survival (rPFS) Secondary Study Endpoints: Time to prostate-specific antigen (PSA) progression Time to next bone-related event (including fractures, spinal cord compression, radiation therapy, or surgery targeting the bones) Time to initiation of subsequent anti-prostate cancer treatment Objective response rate (ORR) Quality of life assessment scores
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted